The Health Resources and Services Administration (HRSA) has delayed until March 21 the effective date of the final rule on drug ceiling prices and manufacturer civil monetary penalties under the 340B Drug Pricing Program. The original enforcement date of April 1 is still in place.

The rule — originally slated to go into effect on March 6 — was delayed in accordance with a recent White House memorandum that placed a temporary freeze on pending regulations until incoming department or agency heads have the opportunity to review and approve the regulations.

Contact Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.